Study of Missing Beta-tubulin Component of C3orf33 Protein (G285315)

Target Name: C3orf33

NCBI ID: G285315

C3orf33

Study of Missing Beta-tubulin Component of C3orf33 Protein

C3orf33 (AC3-33) is a protein that is expressed in various tissues of the body, including the brain, heart, and lungs. It is a member of the superfamily of cytoskeletal proteins, which are involved in the structure and function of cells. C3orf33 is unique because it is missing a key component of its cytoskeleton, known as the protein beta-tubulin. This absence has led to the conclusion that C3orf33 may have unique functions, and it is a drug target (or biomarker) of interest.

The study of C3orf33 began in 2008, when a research team led by Dr. Xun Li at the University of California, San Diego identified the protein in brain tissue using a technique called mass spectrometry. They found that C3orf33 was expressed in the brain and that it was highly conserved across different species, suggesting that it may be a universal protein.

Subsequent studies have confirmed that C3orf33 is a critical protein for the structure and function of the cytoskeleton. It is involved in the organization and stability of microtubules, which are the building blocks of the cytoskeleton.Microtubules are made up of two main components: the protein alpha-tubulin and the protein beta-tubulin. alpha-tubulin is the protein that provides the structural stability to the microtubules, while beta-tubulin is responsible for the movement of the microtubules.

C3orf33 is specifically interested because it is missing the beta-tubulin component of the microtubules. This absence suggests that C3orf33 may have its own unique function, or it may be a drug target (or biomarker) of interest.

One of the key functions of the cytoskeleton is the regulation of cell division and growth. Cytoskeletal proteins play a critical role in this process by helping to maintain the structure and stability of the cell's cytoskeleton. In the case of C3orf33, its absence may have implications for the regulation of cell division and growth.

Another potential function of C3orf33 is its role in the development and progression of diseases. The study of C3orf33 has identified that it is expressed in the brain and that it is highly conserved across different species. This suggests that C3orf33 may be a useful biomarker for the diagnosis and treatment of various diseases.

In addition to its potential functions as a drug target (or biomarker), C3orf33 is also of interest to researchers because of its unique structure. The absence of the beta-tubulin component of its cytoskeleton has led to the conclusion that C3orf33 may have a unique mechanism of action. This may have implications for the development of new treatments for various diseases.

Overall, the study of C3orf33 has identified a protein that is expressed in various tissues of the body and is involved in the structure and function of the cytoskeleton. Its unique absence of the beta-tubulin component and its potential functions as a drug target (or biomarker) make it an intriguing study. Further research is needed to fully understand the role of C3orf33 in the regulation of cell division and growth, and to explore its potential as a new treatment option for various diseases.

Protein Name: Chromosome 3 Open Reading Frame 33

Functions: Secreted protein may play a role in transcription regulation via the MAPK3/MAPK1 pathway through an unidentified receptor on the plasma membrane

The "C3orf33 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about C3orf33 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets